// App-Quantinova.ai

P376 : Effects of IV vedolizumab on health-related quality of life and work productivity in patients with Crohn’s disease: results from the Phase 3b VERSIFY trial

Researchers

Presenter

  • S Danese

Principal Investigators

  • S Adsul

  • D Lindner

  • S Jones

  • H Patel

  • J-F Colombel

Medical Centers

  • Humanitas University, Rozzano, Italy

  • Takeda Pharmaceutical International AG, Zürich, Switzerland

  • Takeda Development Centre Europe Ltd., London, UK

  • Takeda Pharmaceuticals International, Deerfield, IL

  • Icahn School of Medicine at Mount Sinai, New York, NY

Locations

  • Italy

  • Switzerland

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Entyvio

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved